2026.08.31
Meet Us at the ESPE (European Society for Paediatric Endocrinology) 2026.
Efpegerglucagon in Congenital Hyperinsulinism: Preliminary Patient Baseline and Demographic Characteristics from the ACHIEVE Phase 2 Study
- Presentation Number
- RFC8.3
- Session
- Poster Session, Tuesday 8 September ~ Thursday 10 September 14:00 CEST, Garden Level
- Presenter
-
Diva De León-Crutchlow /
The Children's Hospital of Philadelphia
Efpegerglucagon in Congenital Hyperinsulinism: Preliminary Patient Baseline and Demographic Characteristics from the ACHIEVE Phase 2 Study
- Presentation Number
- RFC8.3
- Session
- Rapid Free Communications 8 - Late Breaking, Wednesday 9 September, 09:40 - 09:45, Room Le Goudes 2
- Presenter
-
Diva De León-Crutchlow /
The Children's Hospital of Philadelphia
